US Pharmaceutical Lobbying Group Plans to Launch Website to Help Patients Access Cheaper Medications

Deep News
09/29

The Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. pharmaceutical industry's lobbying organization, announced on Monday that it will launch a new website in January next year designed to help patients purchase prescription drugs directly from manufacturers, bypassing pharmacy benefit managers (PBMs) and other intermediaries.

The website, called AmericasMedicines, will allow pharmaceutical companies to list medications available for direct purchase and provide patients with lower-priced access and fewer barriers to obtaining their medications.

The biopharmaceutical industry is attempting to streamline Americans' access to medications and reduce out-of-pocket costs following increasing pressure from the Trump administration.

Trump has consistently urged pharmaceutical companies to align U.S. drug prices with those paid by other countries and signed an executive order in May requiring pharmaceutical manufacturers to offer Americans the same prices available overseas.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10